Investigation into the impact of mast cell activation on the vasculature during chronic lung diseases
In plain English
AI plain-English summaryMast cells—immune cells best known for triggering allergic reactions—are tearing apart the tiny blood vessels that keep lungs healthy. One in five people in the UK live with a chronic lung disease such as asthma or COPD, and that number is rising. While inflammation in the airways gets most of the attention, the dense network of blood vessels that supply oxygen and remove waste from lung tissue is quietly damaged during chronic disease. The researcher has already shown that mast cells can disrupt pericytes—the cells that wrap around blood vessels and keep them stable—in other parts of the body. This project asks whether the same thing happens in the lungs, where both mast cells and pericytes are abundant. The project combines mouse models, human tissue samples, spatial transcriptomics, and 3D imaging to track how overactive mast cells cause pericyte loss and what that does to lung blood vessel function. If the work identifies specific mast-cell-derived factors—such as proteases—that drive this damage, those molecules could become targets for new drugs. The goal is to prevent pericyte dysfunction and, ultimately, slow or stop the vascular damage that worsens chronic lung disease.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Career Development AwardPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know